DENVER, Oct. 22, 2014 /PRNewswire/ -- DaVita Kidney Care,
a division of DaVita HealthCare Partners Inc. (NYSE: DVA), today
announced it has finalized its comprehensive settlement with the
U.S. Department of Justice and certain other federal
agencies regarding allegations of improperly structured joint
ventures with certain physician partners.
As announced in February of this year, DaVita Kidney Care will be subject to a
Corporate Integrity Agreement and an independent monitor to oversee
certain future joint ventures. The agreement also includes a
repayment to the government and a provision requiring executive
certification of quarterly and annual compliance reports.
The following statement is attributable to DaVita Kidney Care:
We are pleased to announce a civil resolution of the
government's thorough review of our joint venture practices
that covered more than a decade's worth of transactions. Patient
care was never at issue, nor were billing or payment practices.
We are proud of our commitment to compliance over our 15-year
history. We have worked incredibly hard to get things right and it
is our belief there was no intentional wrongdoing.
We believe this settlement is the right thing for our teammates,
partners and shareholders. It allows us to move forward with
heightened clarity and transparency, both with regulators and our
physician partners. As part of the settlement we will undo 11 joint
venture transactions covering 26 of our 2,119 clinics.
We thank our teammates and physicians for their uninterrupted
dedication to providing the highest quality care in the industry to
the nearly 170,000 kidney care patients we serve in the U.S. This
commitment is reflected in the government's recent annual Quality
Improvement Program report card which shows DaVita leading the
industry in all quality indicators measured.
About DaVita Kidney
Care
DaVita Kidney
Care is a division of DaVita HealthCare Partners Inc. a
Fortune 500(r) company that, through its operating divisions,
provides a variety of health care services to patient populations
throughout the United States and
abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic
kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients'
quality of life by innovating clinical care, and by offering
integrated treatment plans, personalized care teams and convenient
health-management services. As of June 30,
2014, DaVita Kidney Care
operated or provided administrative services at 2,119 outpatient
dialysis centers located in the United
States serving approximately 168,000 patients. The company
also operated 84 outpatient dialysis centers located in 10
countries outside the United
States. DaVita Kidney Care
supports numerous programs dedicated to creating positive,
sustainable change in communities around the world. The company's
leadership development initiatives and social responsibility
efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu. For more information, please
visit DaVita.com.
Contact Information
Media:
Skip Thurman
303-876-6610
Skip.thurman@davita.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/davita-kidney-care-finalizes-doj-settlement-842642650.html
SOURCE DaVita Kidney Care